WSJ — Making Psychedelics Mainstream

From today’s WSJ, Antonio and Genevieve are doing great work to advance a renaissance in mental health treatments, for PTSD, depression, anxiety, opioid and alcohol addiction, OCD, anorexia, traumatic brain injury, even stroke and chemotherapy recovery.

Closing WSJ quote today: “A year from now, I hope we’ll have multiple FDA-approved psychedelic therapies so patients can safely access treatment under the care of trained medical professionals,” Genevieve Jurvetson said.” — Full WSJ article